SIRT1 silencing confers neuroprotection through IGF-1 pathway activation

Journal of Cellular Physiology

Volumn 228, Issue 8, 2013, Pages 1754-1761

  Sansone, Luigi ^a,b   Reali, Valentina ^a   Pellegrini, Laura ^a,c   Villanova, Lidia ^a,d   Aventaggiato, Michele ^a   Marfe, Gabriella ^e   Rosa, Roberta ^f,g   Nebbioso, Marcella ^a   Tafani, Marco ^a   Fini, Massimo ^b   Russo, Matteo A ^a,b   Pucci, Bruna ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b IRCCS SAN RAFFAELE PISANA   (Italy)

^c UNIVERSITY OF HAWAII CANCER CENTER   (United States)

^d STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF ROME TOR VERGATA   (Italy)

^f UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^g UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; SIRTUIN 1; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; FLOW CYTOMETRY; MOUSE; NERVE CELL DIFFERENTIATION; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; CELL DEATH; CELL DIFFERENTIATION; CELL LINE; CELL SURVIVAL; DOWN-REGULATION; INSULIN-LIKE GROWTH FACTOR I; MICE; NEURONS; NEUROPROTECTIVE AGENTS; RATS; RECEPTOR, IGF TYPE 1; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SIRTUIN 1; UP-REGULATION;

EID: 84876720051     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24334     Document Type: Article

References (36)

1. Araki T, Sasaki Y, Milbrandt J. 2004. Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science 305:1010-1013.
2. Bordone L, Motta MC, Picard F, Robinson A, Jhala US, Apfeld J, McDonagh T, Lemieux M, McBurney M, Szilvasi A, Easlon EJ, Lin SJ, Guarente L. 2006. Sirt1 regulates insulin secretion by repressing UCP2 in pancreatic beta cells. PLoS Biol 4:e31. Erratum in: PLoS Biol 2006; 4: e295.
3. Broughton S, Partridge L. 2009. Insulin/IGF-like signaling, the central nervous system and aging. Biochem J 418:1-12.
4. Chen D, Steele AD, Hutter G, Bruno J, Govindarajan A, Easlon E, Lin SJ, Aguzzi A, Lindquist S, Guarente L. 2008. The role of calorie restriction and SIRT1 in prion-mediated neurodegeneration. Exp Gerontol 43:1086-1093.
5. Chong ZZ, Lin SH, Li F, Maiese K. 2005. The sirtuin inhibitor nicotinamide enhances neuronal cell survival during acute anoxic injury through AKT, BAD, PARP, and mitochondrial associated "anti-apoptotic" pathways. Curr Neurovasc Res 2:271-285.
6. D'Ercole AJ, Ye P, Calikoglu AS, Gutierrez-Ospina G. 1996. The role of the insulin-like growth factors in the central nervous system. Mol Neurobiol 13:227-255.
7. Fulco M, Schiltz RL, Iezzi S, King MT, Zhao P, Kashiwaya Y, Hoffman E, Veech RL, Sartorelli V. 2003. Sir2 regulates skeletal muscle differentiation as a potential sensor of the redox state. Mol Cell 12:51-62. Erratum in: Mol Cell 2005; 20: 491.
8. Gao J, Wang WY, Mao YW, Graff J, Guan JS, Pan L, Mak G, Kim D, SU SC, Tsai LH. 2010. A novel pathway regulates memory and plasticity via SIRT1 and miR-134. Nature 466:1105-1109.
9. Guan J, Miller OT, Waugh KM, McCarthy DC, Gluckman PD. 2001. Insulin-like growth factor-1 improves somatosensory function and reduces the extent of cortical infarction and ongoing neuronal loss after hypoxia-ischemia in rats. Neuroscience 105:299-306.
10. Guan J, Bennet L, Gluckman PD, Gunn AJ. 2003. Insuline-like growth factor-1 and post-ischemic brain injury. Prog Neurobiol 70:443-462.
11. Guarente L. 2011. Sirtuins, aging, and medicine. N Engl J Med 364:2235-2244.
12. Hasegawa K, Yoshikawa K. 2008. Necdin regulates p53 acetylation via Sirtuin1 to modulate DNA damage response in cortical neurons. J Neurosci 28:8772-8784.
13. Heck S, Lezoualch F, Engert S, Behl C. 1999. Insulin-like growth factor-1-mediated neuroprotection against oxidative stress is associated with activation of nuclear factor kappa B. J Biol Chem 274:9828-9835.
14. Holland MA, Tan AA, Smith DC, Hoane MR. 2008. Nicotinamide treatment provides acute neuroprotection and GFAP regulation following fluid percussion injury. J Neurotrauma 25:140-152.
15. Kakefuda K, Fujita Y, Oyagi A, Hyakkoku K, Kojima T, Umemura K, Tsuruma K, Shimazawa M, Ito M, Nozawa Y, Hara H. 2009. Sirtuin 1 overexpression mice show a reference memory deficit, but not neuroprotection. Biochem Biophys Res Commun 387:784-788.
16. Kim D, Nguyen MD, Dobbin MM, Fischer A, Sananbenesi F, Rodgers JT, Delalle I, Baur JA, Sui G, Armour SM, Puigserver P, Sinclair DA, Tsai LH. 2007. SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J 26:3169-3179.
17. Langley E, Pearson M, Faretta M, Bauer UM, Frye RA, Minucci S, Pelicci PG, Kouzarides T. 2002. Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular senescence. EMBO J 21:2383-2396.
18. Laviola L, Natalicchio A, Giorgino F. 2007. The IGF-I signaling pathway. Curr Pharm Des 13:663-669.
19. Li Y, Xu W, McBurney MW, Longo VD. 2008. SirT1 inhibition reduces IGF-I/IRS-2/Ras/ERK1/2 signaling and protects neurons. Cell Metab 8:38-48.
20. Liu D, Pitta M, Mattson MP. 2008. Preventing NAD(+) depletion protects neurons against excitotoxicity: Bioenergetic effects of mild mitochondrial uncoupling and caloric restriction. Ann NY Acad Sci 1147:275-282.
21. Liu D, Gharavi R, Pitta M, Gleichmann M, Mattson MP. 2009. Nicotinamide prevents NAD+ depletion and protects neurons against excitotoxicity and cerebral ischemia: NAD+ consumption by SIRT1 may endanger energetically compromised neurons. Neuromolecular Med 11:28-42.
22. Longo VD. 2009. Linking sirtuins, IGF-I signaling, and starvation. Exp Gerontol 44:70-74.
23. Markowska AL, Mooney M, Sonntag WE. 1998. Insulin-like growth factor-1 ameliorates age-related behavioral deficits. Neuroscience 87:559-569.
24. Motta MC, Divecha N, Lemieux M, Kamel C, Chen D, Gu W, Bultsma Y, McBurney M, Guarente L. 2004. Mammalian SIRT1 represses forkhead transcription factors. Cell 116:551-563.
25. Nemoto S, Fergusson MM, Finkel T. 2005. SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1{alpha}. J Biol Chem 280:16456-16460.
26. Pfister JA, Ma C, Morrison BE, D'Mello SR. 2008. Opposing effects of sirtuins on neuronal survival. SIRT1-mediated neuroprotection is independent of its deacetylase activity. PLoS ONE 3:e4090.
27. Picard F, Kurtev M, Chung N, Topark-Ngarm A, Senawong T, Machado De Oliveira R, Leid M, McBurney MW, Guarente L. 2004. Sirt1 promotes fat mobilization in white adipocytes by repressing PPAR-gamma. Nature 429:771-776. Erratum in Nature 2004; 430: 921.
28. Pucci B, Bertani FR, Indelicato M, Sale P, Lococo E, Grassi F, Pagani F, Colafrancesco V, Morgante E, Tafani M, Fini M, Russo MA. 2008. Insuline-like Growth factor-1 inhibits STS-induced cell death and increases functional recovery of in vitro differentiated neurons. Cell Cycle 7:3869-3877.
29. Qin W, Yang T, Ho L, Zhao Z, Wang J, Chen L, Zhao W, Thiyagarajan M, MacGrogan D, Rodgers JT, Puigserver P, Sadoshima J, Deng H, Pedrini S, Gandy S, Sauve AA, Pasinetti GM. 2006. Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction. J Biol Chem 281:21745-21754.
30. Rathbone CR, Booth FW, Lees SJ. Sirt1 increases skeletal muscle precursor cell proliferation. Eur J Cell Biol 2009. 88:35-44.
31. Taguchi A, Wartschow LM, White MF. 2007. Brain IRS2 signaling coordinates life span and nutrient homeostasis. Science 317:369-372.
32. Tang BL. 2010. Resveratrol is neuroprotective because it is not a direct activator of Sirt1-A hypothesis. Brain Res Bull 81:359-361.
33. Trejo JL, Carro E, Garcia-Galloway E, Torres-Aleman I. 2004. Role of insulin-like factor growth I signaling in neurodegenerative diseases. J Mol Med 82:156-162.
34. Van der Heide LP, Ramakers GM, Smidt MP. 2006. Insulin signaling in the central nervous system: Learning to survive. Prog Neurobiol 79:205-221.
35. Vaziri H, Dessain SK, Ng Eaton E, Imai SI, Frye RA, Pandita TK, Guarente L, Weinberg RA. 2001. hSIR2(SIRT1) functions as an NAD-dependent p53 deacetylase. Cell 107:149-159.
36. Yeung F, Hoberg JE, Ramsey CS, Keller MD, Jones DR, Frye RA, Mayo MW. 2004. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 23:c2369-c2380.